Evidence map›Paper›PMID 31449536›Full record

ArticlePloS one2019

Clinical features of chronic cluster headache based on the third edition of the International Classification of Headache Disorders: A prospective multicentre study.

Soo-Jin Cho, Mi Ji Lee, Byung-Kun Kim, Heui-Soo Moon, Pil-Wook Chung, Jong-Hee Sohn, Soo-Kyoung Kim, Yunju Choi, Tae-Jin Song, Jae-Moon Kim and 10 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Observational
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 16 institutions in 1 country.

Soo-Jin ChoDepartment of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea.
Mi Ji LeeDepartment of Neurology, Neuroscience Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID 0000-0003-1364-1969
Byung-Kun KimDepartment of Neurology, Eulji University School of Medicine, Seoul, Korea.
Heui-Soo MoonDepartment of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pil-Wook ChungDepartment of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jong-Hee SohnDepartment of Neurology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Korea.
Soo-Kyoung KimDepartment of Neurology, Gyeongsang National University College of Medicine, Jinju, Korea.
Yunju ChoiDepartment of Neurology, Presbyterian Medical Center, Jeonju, Korea.
Tae-Jin SongDepartment of Neurology, Ewha Womans University School of Medicine, Seoul, Korea.
Jae-Moon KimDepartment of Neurology, Chungnam National University College of Medicine, Daejeon, Korea.
Daeyoung KimDepartment of Neurology, Chungnam National University College of Medicine, Daejeon, Korea.
Jeong Wook ParkDepartment of Neurology, Uijeongbu St.Mary's Hospital, The Catholic University of Korea College of Medicine, Uijeongbu, Korea.
Kwang-Yeol ParkDepartment of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Jae-Myun ChungDepartment of Neurology, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
Jin-Young AhnDepartment of Neurology, Seoul Medical Center, Seoul, Korea.
Byung-Su KimDepartment of Neurology, Bundang Jesaeng General Hospital, Seongnam, Korea.
Kyungmi OhDepartment of Neurology, Korea University College of Medicine, Seoul, Korea.
Dae-Woong BaeDepartment of Neurology, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Min Kyung ChuDepartment of Neurology, Severance Hospital, Yonsei University School of Medicine, Seoul, Korea.ORCID 0000-0001-6221-1346
Chin-Sang ChungDepartment of Neurology, Neuroscience Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Chungnam National University · KREulji University · KRKangbuk Samsung Hospital · KRSamsung Medical Center · KRCatholic University of Korea · KRChung-Ang University Hospital · KREwha Womans University · KRGyeongsang National University · KRHallym University · KRHallym University Dongtan Sacred Heart Hospital · KRInje University Seoul Paik Hospital · KRKorea University · KRPresbyterian Medical Center · KRSeoul Medical Center · KRThe Catholic University of Korea Uijeongbu St. Mary's Hospital · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The criterion for the remission period of chronic cluster headache (CCH) was recently revised from < 1 month to < 3 months in the third edition of the International Classification of Headache Disorders (ICHD-3). However, information on the clinical features of CCH based on the ICHD-3 criteria is currently limited. The present study aimed to investigate the clinical features of CCH based on ICHD-3 using data from the Korean Cluster Headache Registry (KCHR). The KCHR is a multicentre prospective registry of patients with cluster headache (CH) from 15 hospitals. Among the 250 participants with CH, 12 and 176 participants were classified as having CCH and episodic cluster headache (ECH), respectively. Among 12 participants with CCH, 6 (50%) had remission periods of < 1 month, and the remaining 6 (50%) had a remission period of 1-3 months. Six participants had CCH from the time of onset of CH, and in the other 6 participants, CCH evolved from ECH. CCH subjects had later age of onset of CH, developed the condition after a longer interval after CH onset, and had more migraine and less nasal congestion and/or rhinorrhoea than ECH subjects. Clinical features of CCH with remission periods < 1 month were not significantly different from those of CCH with remission periods of 1-3 months, except for the total number of bouts. More current smoking and less diurnal rhythmicity were observed in participants with CCH evolved from ECH compared to those with ECH. In conclusion, the number of subjects with CCH doubled when the revised ICHD-3 criteria were used. Most of clinical characteristics of CCH did not differ when the previous and current version of ICHD was applied and compared. Some clinical features of CCH were different from those of ECH, and smoking may have a role in CH chronification.

Indexed as

AdultCluster HeadacheFemaleHeadacheHumansMaleMiddle AgedMigraine Disorders

Identifiers

PMID31449536
PMCPMC6709915
OpenAlexW2971250401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.